Alergia e Imunologia
Série de casos | Plasmaférese em 3 pacientes com trombocitopenia trombótica imune induzida por vacina.
8 Jul, 2021 | 09:56h
Comentário no Twitter
Three patients with severe manifestations of VITT after #COVID19 vaccination had poor response to initial therapy with anticoagulants and intravenous immune globulin. Their condition improved after therapeutic plasma exchange was initiated.
— NEJM (@NEJM) July 7, 2021
Novas evidências sugerem que a vacina Sputnik contra COVID é segura e eficaz.
8 Jul, 2021 | 09:55hMounting evidence suggests Sputnik COVID vaccine is safe and effective – Nature
Perspectiva | Pessoas com problemas imunológicos deveriam tomar uma 3ª dose de vacina?
8 Jul, 2021 | 09:51hShould People With Immune Problems Get Third Vaccine Doses? – The New York Times (poucos artigos gratuitos por mês)
Relacionado: [Preprint] 3rd AstraZeneca shot gives strong immunity. E Case series: Safety and immunogenicity of a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients.
Declaração Conjunta COVAX sobre o Reconhecimento Igualitário de Vacinas | COVAX cobra que todas as autoridades governamentais reconheçam como vacinadas todas as pessoas que receberam vacinas contra COVID-19 atestadas como seguras e eficazes pela OMS.
5 Jul, 2021 | 10:30hJoint COVAX Statement on the Equal Recognition of Vaccines – World Health Organization
Comentário no Twitter (fio – clique para saber mais)
#COVAX urges all government authorities to recognize as fully vaccinated all who have received #COVID19 vaccines approved by WHO or one of 11 approved Stringent Regulatory Authorities, when making decisions on who is able to travel or attend events.
👉https://t.co/udYVrYTdMg pic.twitter.com/DihCPUmS8F
— World Health Organization (WHO) (@WHO) July 1, 2021
Opinião | Covid é um risco muito maior para os jovens do que as vacinas.
5 Jul, 2021 | 10:27hCovid Is a Greater Risk to Young People Than the Vaccines – The New York Times
Contraponto: Weighing myocarditis cases, ACIP failed to balance the harms vs benefits of 2nd doses – by Wesley Pegden E Vaccine-Induced Myocarditis Concerns Demand Respect, Not Absolutism – Medscape (necessário cadastro gratuito)
Comentário no Twitter
“Realize the choice is not ‘vaccinate or do nothing.’ It’s ‘vaccinate or eventually contract the coronavirus,’ and the risks that come with it.”
My latest with @celinegounder and @EMDocinTraining@NYTOpinion @acsifferlin https://t.co/wGugCuWgSs
— Jeremy Faust MD MS (ER physician) (@jeremyfaust) July 4, 2021
Comparativo das vacinas contra Covid | Um grande sucesso, um grande erro e mistura de vacinas: a marca de 18 meses.
5 Jul, 2021 | 10:23hA Big Hit, A Big Miss, & Mixed Vaccine Schedules: The 18-Month Mark – Absolutely Maybe Blog
Comentário no Twitter
My latest roundup on Covid vax: a big hit, a big miss, & mixed vaccine schedules. 15 vaxes with phase 3 results coming up to the 18-month mark! More than 20 controlled community impact studies now, & lots on immunocompromise | New @PLOS https://t.co/HEsuFc4af3 #IC
— Hilda Bastian, PhD (@hildabast) July 2, 2021
Por que os surtos de Covid-19 em países que usaram vacinas chinesas não significam necessariamente que as doses falharam.
5 Jul, 2021 | 10:20hO que são as vacinas da Sinopharm e da Sinovac? E quão eficazes elas são? Dois especialistas explicam.
5 Jul, 2021 | 10:16hAlemanha emite recomendação quanto à mistura de vacinas contra Covid-19.
5 Jul, 2021 | 10:15hGermany issues world’s strongest recommendation for mixing Covid-19 vaccines – CNN
[Preprint] Estudo mostra que misturar vacinas contra Covid traz uma boa resposta imunológica – “O estudo Com-Cov pesquisou a eficácia de 2 doses da vacina da Pfizer, 2 da AstraZeneca e também uma de cada. Todas as combinações funcionaram bem em preparar o sistema imune.”
2 Jul, 2021 | 11:19hMixing Covid jabs has good immune response, study finds – BBC
Estudo original (preprint): Safety and Immunogenicity Report from the Com-COV Study – a Single-Blind Randomised Non-Inferiority Trial Comparing Heterologous And Homologous Prime-Boost Schedules with An Adenoviral Vectored and mRNA COVID-19 Vaccine – SSRN Preprints with the Lancet